找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Key Statistical Concepts in Clinical Trials for Pharma; J. Rick Turner Book 2012 The Author(s) 2012 Clinical Trials.Pharma.Statistical Con

[復(fù)制鏈接]
樓主: HEMI
21#
發(fā)表于 2025-3-25 06:00:06 | 只看該作者
Book 2012a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to ap
22#
發(fā)表于 2025-3-25 10:06:23 | 只看該作者
Setting the Scene,f safety and efficacy by using procedures that everyone has agreed to honor. Not everyone needs to be an expert in Statistics, but everyone engaged in drug development can benefit considerably from a solid conceptual understanding of drug safety and efficacy, clinical significance, statistical significance, and benefit-risk assessments.
23#
發(fā)表于 2025-3-25 13:26:34 | 只看該作者
Assessing Efficacy Data,onstration of statistically significant efficacy alone does not equate to the demonstration of a biologically and medically important degree of efficacy. Statistical significance addresses the reliability of the treatment effect, while clinical significance addresses the magnitude of the treatment effect, i.e., its degree of therapeutic benefit.
24#
發(fā)表于 2025-3-25 17:53:03 | 只看該作者
25#
發(fā)表于 2025-3-25 22:50:42 | 只看該作者
Meta-Methodology,s more power than any of the individual trials incorporated could provide; evaluating an effect in a subgroup of participants, or a rare adverse event in all participants; and assessing the possibility of a systematic effect among apparently conflicting study results.
26#
發(fā)表于 2025-3-26 03:11:51 | 只看該作者
27#
發(fā)表于 2025-3-26 06:59:17 | 只看該作者
28#
發(fā)表于 2025-3-26 09:53:15 | 只看該作者
Analyzing Safety Data,tent of the label will have been agreed upon by the Sponsor and the regulatory agency granting marketing approval, and it summarizes the best available data about the drug’s safety at that point in time.
29#
發(fā)表于 2025-3-26 12:47:21 | 只看該作者
uralleiste die ersten afferenten Neurone hervor, welche die sensorischen Spinal- und Hirnnervenganglien bilden. Weiter entstammen die Zellen der sympathischen Ganglien (Grenzstrang), die Schwann-Zellen, die chromaffinen Zellen des Nebennierenmarks, die Melanozyten und das Mesektoderm dem Neuralleist
30#
發(fā)表于 2025-3-26 17:54:56 | 只看該作者
J. Rick Turner Ph.duralleiste die ersten afferenten Neurone hervor, welche die sensorischen Spinal- und Hirnnervenganglien bilden. Weiter entstammen die Zellen der sympathischen Ganglien (Grenzstrang), die Schwann-Zellen, die chromaffinen Zellen des Nebennierenmarks, die Melanozyten und das Mesektoderm dem Neuralleist
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 15:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
隆回县| 嵩明县| 营口市| 邵武市| 洛宁县| 木兰县| 竹北市| 绥阳县| 铅山县| 武城县| 布尔津县| 澜沧| 灵宝市| 堆龙德庆县| 万山特区| 玛多县| 江陵县| 高台县| 东海县| 无锡市| 都昌县| 荆门市| 阳原县| 大安市| 清流县| 应城市| 高安市| 岚皋县| 那坡县| 平凉市| 宁乡县| 汉寿县| 多伦县| 普陀区| 兰州市| 阿拉善盟| 安化县| 田阳县| 黄石市| 三穗县| 宕昌县|